There is a problem with the stock price data. Our supplier is working to solve the issue.
Stockholm Stock Exchange | Mid Cap
Camurus
+55.47%
Latest
+44.49%
3 months
Handelsbanken Capital MarketsPareto SecuritiesNordea MarketsDNBCarnegieBryan GarnierJefferiesHandelsbankenDNB Markets

About The Company

Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases.
Wikipedia